← Back to Patent Explorer
US4145542A Expired / Lapsed US ⏱️ 0.0 years remaining

5- 1-Hydroxy-2-(heterocyclic-amino)!alkyl-8-hydroxy-3,4-dihydrocarbostyril derivatives

Assignee: Otsuka Pharmaceutical Co Ltd
•
Filing: 1976-11-29
•
Granted: 1979-03-20
•
Expires: 1996-11-29
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract 5- 1-Hydroxy-2-(heterocyclic-amino)!alkyl-8-hydroxy-3,4-dihydrocarbostyril derivatives having the formula (I) ##STR1## wherein R 1 represents an alkyl group having 1 to 4 carbon atoms and A, when taken together with the nitrogen atom to which it is attached, form a 5- or 6-membered substituted or unsubstituted heterocyclic ring containing 1 or 2 nitrogen, or oxygen atoms as hetero atoms, the pharmaceutically acceptable acid addition salts thereof, and a process for preparing the same.

Inventors

  • 👤 Kazuyuki Nakagawa
  • 👤 Shiro Yoshizaki
  • 👤 Shigeharu Tamada
  • 👤 Kaoru Tanimura

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-30 15:51
CPC Classifications
C; C07; C07D; C07D215/00; C07D215/02; C07D215/16; C07D215/20; C07D215/24; C07D215/26

Claims Analysis

Total Claims: 4
Claim 1
Independent Claim 64 words
A 5- 1-hydroxy-2-(heterocyclic-amino)!alkyl-8-hydroxy-3,4dihydrocarbostyril derivative having the formula ##STR21## wherein R 1 represents an alkyl group having 1 to 4 carbon atoms, and A, when taken together with the nitrogen atom to which it is attached, forma a morpholino or piperazino ring which is unsubstituted or substituted by an alkyl group of 1 to 4 carbon atoms, and the pharmaceutically acceptable acid addition salts thereof.
Claim 2
Dependent Claim 64 words
A 5- 1-hydroxy-2-(heterocyclic-amino)!alkyl-8-hydroxy-3,4dihydrocarbostyril derivative having the formula ##STR21## wherein R 1 represents an alkyl group having 1 to 4 carbon atoms, and A, when taken together with the nitrogen atom to which it is attached, forma a morpholino or piperazino ring which is unsubstituted or substituted by an alkyl group of 1 to 4 carbon atoms, and the pharmaceutically acceptable acid addition salts thereof.
Claim 3
Dependent Claim 5 words
5-(1-Hydroxy-2-morpholino)propyl-8-hydroxy-3,4-dihydrocarbostyril according to claim 1.
Claim 4
Dependent Claim 5 words
5-(1-Hydroxy-2-morpholino)butyl-8-hydroxy-3,4-dihydrocarbostyril according to claim 1.

References Cited (Backward Citations)

US3994901A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1982-03-19 1982-09-18 1983-03-20 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1986-03-19 1986-09-18 1987-03-20 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1990-03-19 1990-09-18 1991-03-20 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag